The Schedule of Pharmaceutical Benefits was updated on 1 November 2023. New, Amended and Deleted items can be found on the Summary of Changes page.

The following updates have also been made to the PBS Website on the dates specified.

• Ex-manufacturer price - 1 November 2023
• Formulary Allocations - 1 November 2023
• PBS arrangements during shortage of amoxicillin and clavulanate potassium 400 mg/57 mg per 5 mL oral suspension effective 1 November 2023 - 1 November 2023
• Listings on the PBS for Aboriginal and Torres Strait Islander people - 1 November 2023
• Medicine Status Website - 1 November 2023
• Updates to the HTA Review Research and analysis papers collection: Draft HTA expert paper published - 30 October 2023
• Expressions of Interest to join the Pharmaceutical Benefits Remuneration Tribunal - 30 October 2023
• Updated Agenda for November 2023 PBAC Meeting – 30 October 2023
• PBAC Public Summary Documents – July 2023 meeting - 27 October 2023
• Drugs and manners of administration that meet the 42 month clock - 27 October 2023
• Drugs and manners of administration that meet the 30 month clock - 27 October 2023
• Updates to the HTA Review Research and analysis papers collection: Draft HTA expert papers published - 25 October 2023
• Opioid Dependence Treatment Program - 24 October 2023
• Updates to the HTA Policy and Methods Review Reference Committee – 23 October 2023
• 1 November 2023 Changes to the PBS Listings of Medicines for Severe Active Rheumatoid Arthritis - 23 October 2023
• 1 November 2023 changes to the PBS listings of medicines for children and adolescents with Chronic Plaque Psoriasis - 23 October 2023
• Outcomes of the September 2023 PBAC Intracycle meeting - 13 October 2023
• PBS and RPBS Section 85 Date of Supply Data - 12 October 2023
• Updates to the HTA Policy and Methods Review Reference Committee – October 2023 - 11 October 2023
• Updates to the HTA Policy and Methods Review Reference Committee – 11 October 2023